Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 293 insiders at 194 companies
- $6.3B sold by 282 insiders outside a trading plan
- $3.3B sold by 627 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Nello Mainolfi CEOKYMRKymera Therapeutics, Inc.Planned sale$3.4M 30,000 shares at $113.80 4.3% of stakeTraded Oct 1 Filed Oct 1
-
George Kurian CEONTAPNetApp, Inc.Planned sale$10.5M 50,000 shares at $209.95 19% of stakeTraded Sep 29 Filed Oct 1
-
Matthew J Cox CEOMATXMatson, Inc.Planned sale$2.2M 10,000 shares at $222.33 4.4% of stakeTraded Sep 29 Filed Oct 1
-
Ian Mortimer CEOXENEXenon Pharmaceuticals Inc.Buy$1.1M 30,000 shares at $37.38 +151% to stakeTraded Sep 30 Filed Oct 1
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.2M 20,000 shares at $258.20 0.3% of stakeTraded Sep 28–29 Filed Sep 30
-
Michael Hsing CEOMPWRMonolithic Power Systems, Inc.Planned sale$40.3M 30,000 shares at $1,344.97 3.5% of stakeTraded Sep 28 Filed Sep 30
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $477.42 2.8% of stakeTraded Sep 29 Filed Sep 30
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.5M 66,000 shares at $98.19 24% of stakeTraded Sep 29–30 Filed Sep 30
-
Kevin J McNamara CEOCHEChemed Corp.Sale$1M 2,000 shares at $513.45 2.9% of stakeTraded Sep 28 Filed Sep 30
-
Richard H Moore CEOFBNCFirst BancorpSale$1.5M 23,343 shares at $62.85 22% of stakeTraded Sep 28–29 Filed Sep 30
-
Philip Andrew Smith CEOSNEXStoneX Group Inc.Planned sale$3.7M 56,250 shares at $65.69 7.1% of stakeTraded Sep 28 Filed Sep 29
-
Jayshree Ullal CEOANETArista Networks, Inc.Planned sale$13.2M 62,622 shares at $211.40 0.4% of stakeTraded Sep 25 Filed Sep 29
-
Ryan Cohen CEOGMEGameStop CorporationBuy$10.6M 450,000 shares at $23.48 +1.1% to stakeTraded Sep 29 Filed Sep 29
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.6M 9,500 shares at $480.85 2.8% of stakeTraded Sep 28 Filed Sep 29
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$1.6M 2,564 shares at $620.10 0.7% of stakeTraded Sep 25–28 Filed Sep 29
-
Yongdong Peng CEOBEKEKE Holdings IncSale$84.6M 16M shares at $5.27 20% of stakeTraded Sep 25 Filed Sep 29
-
Chandler Robinson CEOMNPRMonopar Therapeutics Inc.Planned sale$2.6M 29,056 shares at $88.00 23% of stakeTraded Sep 24 Filed Sep 28
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.2M 20,000 shares at $258.12 0.3% of stakeTraded Sep 24–25 Filed Sep 28
-
Mark Zuckerberg CEOMETAMeta Platforms, Inc., Class APlanned sale$21.4M 27,474 shares at $777.44 2.2% of stakeTraded Sep 24 Filed Sep 28
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6M 61,000 shares at $98.57 18% of stakeTraded Sep 25–28 Filed Sep 28
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $476.17 2.8% of stakeTraded Sep 25 Filed Sep 28
-
George Kurian CEONTAPNetApp, Inc.Planned sale$7.4M 37,000 shares at $199.95 12% of stakeTraded Sep 24 Filed Sep 28
-
Luis Von Ahn CEODUOLDuolingo, Inc.Planned sale$7M 46,682 shares at $150.63 100% of stakeTraded Sep 24 Filed Sep 28
-
Luis A Muller CEOCOHUCohu, Inc.Planned sale$1.8M 27,236 shares at $65.00 3.1% of stakeTraded Sep 25 Filed Sep 25
-
Cristiano R Amon CEOQCOMQUALCOMM IncorporatedPlanned sale$2M 10,000 shares at $200.00 5.3% of stakeTraded Sep 25 Filed Sep 25
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $473.55 2.8% of stakeTraded Sep 24 Filed Sep 25
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$27.4M 43,916 shares at $624.01 10% of stakeTraded Sep 23–24 Filed Sep 25
-
Olivier Loeillot CEORGENRepligen CorporationPlanned sale$2.5M 12,946 shares at $190.00 21% of stakeTraded Sep 24 Filed Sep 25
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.1M 20,000 shares at $253.17 0.3% of stakeTraded Sep 22–23 Filed Sep 24
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$26.7M 307,692 shares at $86.82Traded Sep 22 Filed Sep 24
-
Robert Mionis CEOCLSCelestica, Inc.Planned sale$8.5M 23,396 shares at $364.22 100% of stakeTraded Sep 23 Filed Sep 24
-
Todd McKinnon CEOOKTAOkta, Inc.Planned sale$9.4M 48,822 shares at $193.48 100% of stakeTraded Sep 22 Filed Sep 24
-
Vladimir Tenev CEOHOODRobinhood Markets, Inc.Planned sale$30.2M 240,834 shares at $125.33 100% of stakeTraded Sep 22 Filed Sep 24
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $491.57 2.8% of stakeTraded Sep 23 Filed Sep 24
-
Serge Saxonov CEOTXG10x Genomics, Inc.Planned sale$2M 25,000 shares at $81.22 2.3% of stakeTraded Sep 22 Filed Sep 24
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.8M 69,000 shares at $99.17 17% of stakeTraded Sep 23–24 Filed Sep 24
-
Gary Bowman CEOBWMNBowman Consulting Group Ltd.Planned sale$2.6M 60,000 shares at $42.55Traded Sep 23 Filed Sep 24
-
Eric P Lefkofsky CEOTEMTempus AI, Inc.Planned sale$19.4M 250,000 shares at $77.47 71% of stakeTraded Sep 22 Filed Sep 24
-
Michael D. Sicilia CEOORCLOracle CorporationPlanned sale$3.4M 22,562 shares at $151.59 11% of stakeTraded Sep 22 Filed Sep 23
-
Jonathan Klamkin CEOALMUAeluma, Inc.Planned sale$1.3M 100,000 shares at $13.35 7.5% of stakeTraded Sep 21 Filed Sep 23
-
Daniel Mark Rogers CEOASANAsana, Inc.Planned sale$1.4M 150,175 shares at $9.13 9.2% of stakeTraded Sep 22 Filed Sep 23
-
Luis Von Ahn CEODUOLDuolingo, Inc.Planned sale$6.2M 40,980 shares at $150.65 100% of stakeTraded Sep 21–22 Filed Sep 23
-
D James Bidzos CEOVRSNVerisign Inc.Planned sale$1M 3,300 shares at $304.74 0.8% of stakeTraded Sep 22 Filed Sep 23
-
Joshua J. Ofman CEOGRALGRAIL, Inc.Planned sale$6M 61,452 shares at $97.74 15% of stakeTraded Sep 21 Filed Sep 23
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $494.83 2.8% of stakeTraded Sep 22 Filed Sep 23
-
George Kurian CEONTAPNetApp, Inc.Planned sale$2.6M 13,000 shares at $200.01 4.1% of stakeTraded Sep 21 Filed Sep 23
-
Cristiano R Amon CEOQCOMQUALCOMM IncorporatedPlanned sale$2M 10,000 shares at $195.00 5.1% of stakeTraded Sep 21 Filed Sep 23
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$44.4M 70,901 shares at $626.62 14% of stakeTraded Sep 21–22 Filed Sep 23
-
Vladimir Tenev CEOHOODRobinhood Markets, Inc.Planned sale$32.5M 259,166 shares at $125.58 100% of stakeTraded Sep 21 Filed Sep 23
-
Scott A. Lang CEOATEXAnterix Inc.Planned sale$1.2M 15,000 shares at $80.00 36% of stakeTraded Sep 21 Filed Sep 23
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.